Immediate Impact
2 from Science/Nature 56 standout
Citing Papers
Designing antibodies as therapeutics
2022 Standout
The convalescent sera option for containing COVID-19
2020 Standout
Works of Scott Harkonen being referenced
Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients
1988
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Scott Harkonen | 92 | 68 | 37 | 113 | 98 | 11 | 413 | |
| Gaëlle Pellé | 72 | 26 | 107 | 113 | 206 | 11 | 463 | |
| Mark S. Schiffer | 62 | 20 | 70 | 215 | 150 | 7 | 496 | |
| P Köhler | 152 | 76 | 91 | 51 | 61 | 15 | 497 | |
| Stephen D. Migdal | 50 | 39 | 19 | 126 | 96 | 17 | 417 | |
| C. L. Jones | 45 | 52 | 126 | 69 | 73 | 20 | 390 | |
| Franck Martinez | 24 | 25 | 31 | 137 | 121 | 11 | 380 | |
| Nauman Siddiqi | 56 | 143 | 26 | 104 | 81 | 9 | 456 | |
| Virginie Masse | 58 | 17 | 27 | 55 | 52 | 14 | 386 | |
| Stanley C. Jordan | 87 | 85 | 45 | 192 | 31 | 8 | 407 | |
| Martin Tanner | 128 | 48 | 27 | 18 | 84 | 15 | 499 |
All Works
Loading papers...